Grünenthal GmbH

Jan 29, 2020

Grünenthal Expands Its Network Through Innovation Hub in Boston

Dec 10, 2019

Jan Adams Appointed Chief Scientific Officer for Grünenthal

Jan 22, 2019

Grünenthal: Fabian Raschke Appointed Chief Financial Officer (CFO)

Dec 14, 2018

Grünenthal and OnDosis Team Up for Individualised Dosing of Oral Drugs in Pain Management to Increase Patient Safety

Feb 01, 2018

Grünenthal Group Receives FDA's Expedited Access Pathway Designation for VIVO

Jan 23, 2018

Grünenthal to Distribute, Promote, and Sell MSD's Women's Health Products in Several Countries in Latin America

Jan 15, 2018

Grünenthal and Mundipharma Enter Commercial Partnership in China

Dec 05, 2017

New Partnership for the Commercialization of Nucynta® in the U.S. Territory

Nov 16, 2017

Research Consortium led by Grünenthal Receives EUR 2 Million Grant from the European Fund for Regional Development and the State of North Rhine-Westphalia

Sep 07, 2017

Aging Demographics Require Novel Ideas in Pain Research

Sep 01, 2017

Mark Fladrich Takes Office as the New CCO of the Grünenthal Group

Jun 08, 2017

Contergan Victim Wins Against Former Board Member of the Contergan Foundation

Jun 07, 2017

Grünenthal Enters Agreement with AstraZeneca to Acquire Global Rights to Migraine Treatment Zomig® (Zolmitriptan)